Burning mouth syndrome
Chronic oral burning, normal mucosa · Dental & Oral
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
A chronic burning or scalding sensation of the oral mucosa (typically tongue tip and lips) with clinically normal mucosa and no identifiable local or systemic cause (primary BMS, a neuropathic condition). Secondary causes (deficiency, candidiasis, diabetes, xerostomia, medications) must be excluded first.
Red flags
- Visible mucosal lesion/ulceration (not BMS — investigate)
- Associated weight loss/systemic symptoms
- Progressive neurological symptoms
- Non-healing lesion suggesting malignancy
Assessment
Differential diagnosis
- Nutritional deficiency (iron, B12, folate, zinc)
- Oral candidiasis
- Xerostomia (Sjogren, drugs)
- Diabetes mellitus
- Geographic tongue / oral lichen planus
- Medication effect (ACE inhibitors) / contact allergy
Investigations
- History — burning without visible lesion, often bilateral and worsening through the day
- Oral exam to confirm normal mucosa and exclude candidiasis/lichen planus
- Bloods: FBC, ferritin, B12, folate, glucose/HbA1c, zinc
- Salivary flow assessment / Sjogren screen if dry mouth
- Medication review (ACE inhibitors, others)
- Swab for Candida if suspected
Management
- Exclude secondary causes with history, examination and blood tests
- Correct any identified deficiency, treat candidiasis or xerostomia
- Review and adjust contributory medications where possible
- Explain the diagnosis of primary BMS and its benign, chronic nature (reassurance is therapeutic)
- Advise avoiding irritants (alcohol-containing mouthwashes, spicy/acidic foods, smoking)
- Trial topical or systemic neuropathic agents for primary BMS
- Consider cognitive behavioural therapy / psychological support
- Refer to oral medicine for persistent or diagnostic uncertainty
Drugs & doses
Clonazepam — 0.5 mg sucked/dissolved locally then spat, up to TDS — topical neuropathic effect (specialist)
Nortriptyline/amitriptyline — 10 mg PO nocte, titrated — neuropathic pain (specialist/GP)
Alpha-lipoic acid — 600 mg PO daily — some evidence as adjunct
Artificial saliva / pilocarpine — for associated xerostomia
Disposition
Exclude and treat secondary causes; discharge with reassurance and neuropathic/topical therapy; refer to oral medicine for persistent primary BMS and psychological support as needed.
Complications & pitfalls
- Chronic pain and impaired quality of life
- Anxiety/depression
- Dietary restriction/weight loss
- Missed secondary cause if not screened
Exam pearls
- Diagnosis of primary BMS requires normal mucosa and exclusion of secondary causes
- A clear explanation and reassurance that it is not cancer is itself therapeutic
- Avoid repeated unnecessary investigations once secondary causes are excluded
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.